Table 4.
Results of subgroup meta-analysis
| Outcome | Number of studies | Number | WMD/OR | Tests for HG |
|---|---|---|---|---|
| (sample size) | of patients | (95% CI) (p value) | (p value, I2) | |
| Studies with score of 10 or greater | ||||
| Operative time | 5 | 697 | 12.52 (6.29, 18.74), < 0.0001 | < 0.00001, 88% |
| Complications | 6 | 747 | 1.31 (0.67, 1.2.57), 0.43 | 0.35, 11% |
| Studies with MMV approach | ||||
| Operative time | 5 | 318 | 18.95 (7.36, 30.55), 0.001 | < 0.00001,94% |
| Complications | 6 | 398 | 1.17 (0.51, 2.67), 0.71 | 0.34, 11% |
| Studies with a followup of at least 12 months | ||||
| Complications | 5 | 747 | 1.73 (0.89, 3.36), 0.11 | 0.64, 0% |
HG = heterogeneity; WMD = weighted mean difference; OR = odds ratio; CI = confidence interval; MMV = mini-midvastus.